Fahr syndrome associated to hypoparathyroidy, revealed by dermatologic manifestation;Syndrome de Fahr secondaire à hypoparathyroïdie à révélation dermatologique

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 11, 2004, Pages 979-983

  Khadir, K ^a   Moussaid, L ^a,b   El Ouazzani, T ^a   Gam, I ^a   Slassi, I ^a   Azzouzi, S ^a   Lakhdar, H ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b NONE   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE;

ADOLESCENT; ANAMNESIS; ARTICLE; BACTERIUM DETECTION; CASE REPORT; CENTRAL GRAY MATTER; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG INDICATION; EPILEPSY; ERYTHEMA; FAHR DISEASE; FEMALE; FUNGAL DETECTION; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; IDIOPATHIC DISEASE; LARYNX SPASM; PHOSPHATE BLOOD LEVEL; PUS; PUSTULE; PUSTULOSIS; PYODERMA; RADIODENSITOMETRY; RELAPSE; TETANY;

EID: 10644285720     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93809-4     Document Type: Article

References (26)

1. Rumbach L, Buffler M, Eber AM, Dietemann JL, Collard M. Maladie de Fahr et syndrome de Fahr. J Med Strasbourg 1984;15:375-7.
2. Ceccaldi B, Elmaghraoui A, Mayaudon H, Dupuy O, Eulry F, Bauduceau B. Syndrome de Fahr et hyperparathyroïdie. Presse Med 1999;28:689.
3. El Maghraoui A, Birouk N, Zaim A, Slassi I, Yahyaoui M, Chkili T. Syndrome de Fahr et dysparathyroïdie. 3 observations. Presse Med 1995;24:1301-4.
4. Fenelon C, Guillard A. Maladie de Fahr et calcifications des noyaux gris centraux. Encycl Med Chir (Paris, France), Neurologie, 17062 M10, 10-1987, 3p.
5. Tafani B, Boudouresques C, Turpin JC, Khalil R. Aspects actuels de la maladie de Fahr. Sem Hop Paris 1981;57:1815-8.
6. Geschwind DH, Loginov M, Stern JM. Identification of a locus onchromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 1999;65:764-72.
7. Houman MH, Limam R, Tigourti MN, Kchir MN, Haouet S, Ottanaza M, Miled M. Le syndrome de Fahr. A propos d'un cas révélé par une hémichorée. Sem Hop Paris 1993;69:327-30.
8. Keiralla JC, Tritschler JL, Schlienger JL. Syndrome de Fahr révélé par des crises d'épilepsie. J Med Strasbourg 1990;21:569-71.
9. Rossi M, Morena M, Zanardi M. Calcificazione deigangli della base e malattia di Fahr. Presentazione di due casi clinici e revisione della letteratura. Recent progressi In Medicina 1993;84:192-7.
10. Di Zafeiriou DI, Athanasion M, Katzos G, Economou M, Kontopoulos E. Hypoparathyroidism and intracranial calcifications in beta-thalassemia major. J Pediatr 2001;138:411.
11. Beall SS, Patten BM, Mallette L, Jankovic J. Abnormal systemic metabolism of iron, porphyrin and calcium in Fahr's syndrome. Ann Neurol 1989;26:569-75.
12. Morgane L, Trimarchi F, Benvenga S. Fahr's disease. Lancet 2002;359:759.
13. Beurey J, Weber M, Barthelme D, Vignaud JM, Chaulieu Y. Pustulose amicrobienne spongioforme, hypoparathyroïdie, comitialité- guérison par 25-hydroxy-cholécalciférol (Dedrogyl®). Ann Dermatol Venereol 1980;107:1145-50.
14. Belhadjali H, Youssef M, Amri M, et al. Association psoriasis et syndrome de Fahr. In 24° congrès international de l'association des dermatologistes francophones. Ann Dermatol Venereol 2003;130 (suppl 4):2S53-2S167.
15. Valensi P. Hypoparathyroïdies. Editions techniques: Encycl Med Chir (Paris, France), Endocrinologie-Nutrition 10-012-A10, 1993, 7p.
16. Schmutz JL, Beurey J, Weber M. Pustuloses amicrobiennes et calcium. Ann Dermatol Venereol 1987;114:901-4.
17. Smith EL, Walworth NC, Holick MF. Effect of 1α, 25 dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986;86:709-14.
18. Aubin F, Bressieux JM, Roger M, Degouy A. Vitamin D et ses analogues. In thérapeutique dermatologique, Dubertret L, et al. Ed Flammarion Médecine Sciences 2001:1238-42.
19. Lacour JP, Dubois D, Ortonne JP. Peau et endocrinopathies. Encycl Med Chir (Paris-France), Dermatologie, 12960 A10, 7-1988, 19 p.
20. Hirano K, Ishibachi A, Yoshino Y. Cutaneous manifestations in idiopathic hypoparathyroidism. Arch Dermatol 1974;109:242-4.
21. Hennings H, Michael K, Cheng C, Steinert P, Holbrook K, Yuspa SH. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 1980;19:245-54.
22. Peterson LL, Wuepper KD. Purification of human epidermal calmodulin. J Invest Dermatol 1983;81:68-70.
23. Saurat JH, Didierjean L, Pavlovitch JH, Laouari D, Balsan S. Skin calcium binding in localized in the cytoplasm of the basal layer of the epidermis. J Invest Dermatol 1981;76:221-3.
24. Van De Kerkhof PC, Van Erp PE. Calmodulin levels are grossly elevated in the psoriatic lesion. Br J Dermatol 1983;108:217-8.
25. Wollina U, Klinger R, Wetzker R, Gunter E. Epidermal calmodulin levels in psoriasis. J Invest Dermatol 1987;88:101.
26. Tucker WF, Mac Neil S, Dawson RA, Tomlinson S, Bleehen SS. Calmodulin levels in psoriasis. The effects of treatment. Acta Dermatol Venereol 1986;66:241-4.